Citadel Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,106
| Closed | -$6K | – | 15710 |
|
|
2024
Q1 | $6K | Sell |
26,106
-27,137
| -51% | -$7.88K | ﹤0.01% | 13708 |
|
|
2023
Q4 | $17K | Buy |
+53,243
| New | +$13.7K | ﹤0.01% | 12765 |
|
|
2023
Q3 | – | Sell |
-46,430
| Closed | -$16.9K | – | 15352 |
|
|
2023
Q2 | $23.4K | Buy |
+46,430
| New | +$27.7K | ﹤0.01% | 12594 |
|
|
2023
Q1 | – | Sell |
-44,231
| Closed | -$30K | – | 15727 |
|
|
2022
Q4 | $15.4K | Buy |
+44,231
| New | +$18K | ﹤0.01% | 13333 |
|
|
2022
Q3 | – | Sell |
-461,485
| Closed | -$241K | – | 13849 |
|
|
2022
Q2 | $184K | Sell |
461,485
-1,232,974
| -73% | -$550K | ﹤0.01% | 10797 |
|
|
2022
Q1 | $1.06M | Sell |
1,694,459
-191,141
| -10% | -$147K | ﹤0.01% | 7548 |
|
|
2021
Q4 | $2.09M | Buy |
1,885,600
+1,686,007
| +845% | +$2.61M | ﹤0.01% | 6127 |
|
|
2021
Q3 | $369K | Buy |
199,593
+173,373
| +661% | +$389K | ﹤0.01% | 10591 |
|
|
2021
Q2 | $83K | Sell |
26,220
-2,482,798
| -99% | -$6.21M | ﹤0.01% | 13056 |
|
|
2021
Q1 | $8.15M | Buy |
+2,509,018
| New | +$9.09M | ﹤0.01% | 3295 |
|
|
2020
Q2 | – | Sell |
-90,840
| Closed | -$43.8K | – | 10656 |
|
|
2020
Q1 | $32K | Buy |
+90,840
| New | +$94.8K | ﹤0.01% | 9179 |
|
|
2019
Q3 | – | Sell |
-10,708
| Closed | -$146K | – | 9880 |
|
|
2019
Q2 | $189K | Buy |
+10,708
| New | +$234K | ﹤0.01% | 8232 |
|
|
2019
Q1 | – | Sell |
-13,125
| Closed | -$440K | – | 10007 |
|
|
2018
Q4 | $386K | Sell |
13,125
-12,966
| -50% | -$589K | ﹤0.01% | 6840 |
|
|
2018
Q3 | $1.97M | Buy |
26,091
+17,270
| +196% | +$1.17M | ﹤0.01% | 4435 |
|
|
2018
Q2 | $500K | Buy |
+8,821
| New | +$321K | ﹤0.01% | 6376 |
|
|
2018
Q1 | – | Sell |
-7,474
| Closed | -$171K | – | 8909 |
|
|
2017
Q4 | $188K | Buy |
+7,474
| New | +$230K | ﹤0.01% | 7151 |
|
|
2017
Q3 | – | Sell |
-2,975
| Closed | -$34.6K | – | 8169 |
|
|
2017
Q2 | $27K | Buy |
2,975
+106
| +4% | +$1.01K | ﹤0.01% | 7232 |
|
|
2017
Q1 | $45K | Buy |
2,869
+811
| +39% | +$14.1K | ﹤0.01% | 7066 |
|
|
2016
Q4 | $35K | Buy |
+2,058
| New | +$42.2K | ﹤0.01% | 6952 |
|
|
2015
Q4 | – | Sell |
-151,190
| Closed | -$4.44M | – | 9310 |
|
|
2015
Q3 | $4.44M | Buy |
151,190
+12,801
| +9% | +$475K | ﹤0.01% | 2071 |
|
|
2015
Q2 | $5.4M | Buy |
+138,389
| New | +$6.38M | ﹤0.01% | 1998 |
|
Other funds holding ASXC
BCM
MCM
CM
Citadel Advisors's ASXC Position: Q2 2024 in Review
Citadel Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 26,106 shares — an estimated $6K sold.
Citadel Advisors first reported a position in ASXC in Q2 2015 and held it in 21 quarters. The position peaked at $8.15M in Q1 2021. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.
- Citadel Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
- Citadel Advisors sold 26,106 Asensus Surgical, Inc. shares in Q2 2024, an estimated $6K.
- Citadel Advisors first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 21 quarters.
- Citadel Advisors's Asensus Surgical, Inc. position peaked at $8.15M in Q1 2021.
- 64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.